Bendamustine-based first line therapy in chronic lymphocytic leukemia (CLL) in routine clinical practice: Interim analysis of the German non-interventional study Be-CeLL1st.

Bruch, H.-R., Aldaoud, A., Klausmann, M., Hansen, R., Losem, C., Frank, M., Straßl, L., Ruffert, K., 2014.

Haematologica 99 (suppl 1) (PB1504).

Studie: Be-Cell-1st; Indikation: Hämoblastosen; Jahr: 2014; Veranstaltung: EHA; Journal: Haematologica

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com